BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 32482756)

  • 1. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
    Zhang Y; Ruggiero M; Hagenbuch B
    Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8).
    Maeda K; Kambara M; Tian Y; Hofmann AF; Sugiyama Y
    Mol Pharm; 2006; 3(1):70-7. PubMed ID: 16686371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers.
    Zhang Y; Boxberger KH; Hagenbuch B
    PLoS One; 2017; 12(6):e0180257. PubMed ID: 28644885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers.
    Takehara I; Terashima H; Nakayama T; Yoshikado T; Yoshida M; Furihata K; Watanabe N; Maeda K; Ando O; Sugiyama Y; Kusuhara H
    Pharm Res; 2017 Aug; 34(8):1601-1614. PubMed ID: 28550384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
    Farasyn T; Pahwa S; Xu C; Yue W
    Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
    Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
    Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
    Alam K; Farasyn T; Crowe A; Ding K; Yue W
    PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
    De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
    Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.
    Pahwa S; Alam K; Crowe A; Farasyn T; Neuhoff S; Hatley O; Ding K; Yue W
    J Pharm Sci; 2017 Aug; 106(8):2123-2135. PubMed ID: 28373111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
    Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
    J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ursodeoxycholic and norursodeoxycholic acid as substrates of the hepatic uptake transporters OATP1B1, OATP1B3, OATP2B1 and NTCP.
    König J; Klatt S; Dilger K; Fromm MF
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):81-6. PubMed ID: 22333292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor Method.
    Chan GH; Houle R; Zhang J; Katwaru R; Li Y; Chu X
    Drug Metab Dispos; 2023 Sep; 51(9):1089-1104. PubMed ID: 37137718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
    Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H
    Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
    Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
    PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
    Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
    PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes.
    Izumi S; Nozaki Y; Kusuhara H; Hotta K; Mochizuki T; Komori T; Maeda K; Sugiyama Y
    Mol Pharm; 2018 Jun; 15(6):2277-2288. PubMed ID: 29746136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.
    Hove VN; Anderson K; Hayden ER; Pasquariello KZ; Gibson AA; Shen S; Qu J; Jin Y; Miecznikowski JC; Hu S; Sprowl JA
    Mol Pharmacol; 2022 Jun; 101(6):381-389. PubMed ID: 35383108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.